CRIXIVAN
- Product NDC
- 0006-0573
- 11-digit product format
- 000060573
- Labeler code
- 0006
- Product ID
- 0006-0573_2f1ee2da-8e76-4c4e-8006-285449f74f1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- indinavir sulfate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Merck Sharp & Dohme Corp.
- Application
- NDA020685
- Marketing category
- NDA
- Marketing start
- 1996-03-13
- Marketing end
- 0000-00-00
- Substance
- INDINAVIR SULFATE
- Active strength
- 400 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| eed3583e-78db-412f-aba7-02811a2dc6a8 | Product name | 1 | 20150204 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0006-0573-18 | EA - Each | 0006-0573 | 7c3a9894-de1d-4f03-ad55-9263f5a9b003 | 1 | 2013-02-11 |
| 0006-0573-42 | EA - Each | 0006-0573 | 307ff0ef-46f0-4206-a6ff-c5eefcf0f5f1 | 1 | 2013-02-11 |
| 0006-0573-54 | EA - Each | 0006-0573 | 21b0f3cc-4bd2-409f-bd23-8801ab31a88d | 1 | 2012-07-24 |
| 0006-0573-62 | EA - Each | 0006-0573 | 4b7e8d81-7e29-407c-afd9-a98ecf1b814e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 153128 | Crixivan 400 MG Oral Capsule | PSN | 702727cb-3eff-425b-9573-031332849430 | 3 |
| 310988 | indinavir sulfate 400 MG Oral Capsule | PSN | 702727cb-3eff-425b-9573-031332849430 | 3 |
| 153128 | indinavir 400 MG Oral Capsule [Crixivan] | SBD | 702727cb-3eff-425b-9573-031332849430 | 3 |
| 310988 | indinavir 400 MG Oral Capsule | SCD | 702727cb-3eff-425b-9573-031332849430 | 3 |
| 153128 | Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule | SY | 702727cb-3eff-425b-9573-031332849430 | 3 |
| 153128 | Crixivan 400 MG Oral Capsule | SY | 702727cb-3eff-425b-9573-031332849430 | 3 |
| 310988 | indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule | SY | 702727cb-3eff-425b-9573-031332849430 | 3 |
| 153128 | Crixivan 400 MG Oral Capsule | PSN | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 153128 | Crixivan 400 MG Oral Capsule | PSN | 83aeddf8-6fed-487c-858b-2240f0a0e8af | 1 |
| 310988 | indinavir sulfate 400 MG Oral Capsule | PSN | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir sulfate 400 MG Oral Capsule | PSN | 83aeddf8-6fed-487c-858b-2240f0a0e8af | 1 |
| 153128 | indinavir 400 MG Oral Capsule [Crixivan] | SBD | 83aeddf8-6fed-487c-858b-2240f0a0e8af | 1 |
| 153128 | indinavir 400 MG Oral Capsule [Crixivan] | SBD | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir 400 MG Oral Capsule | SCD | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir 400 MG Oral Capsule | SCD | 83aeddf8-6fed-487c-858b-2240f0a0e8af | 1 |
| 153128 | Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule | SY | 83aeddf8-6fed-487c-858b-2240f0a0e8af | 1 |
| 153128 | Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule | SY | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 153128 | Crixivan 400 MG Oral Capsule | SY | 83aeddf8-6fed-487c-858b-2240f0a0e8af | 1 |
| 153128 | Crixivan 400 MG Oral Capsule | SY | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule | SY | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule | SY | 83aeddf8-6fed-487c-858b-2240f0a0e8af | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0006-0573-62 | 00006057362 | 180 CAPSULE in 1 BOTTLE (0006-0573-62) | 180 capsule | 1996-03-13 | 0000-00-00 | No | No | Current |